Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Murray

Showing results (231-240 of 265) with videos related to

Pageof 27
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|January 20, 2025
Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display libraryStacey E Chin, Pablo Gallego, Anna Aagaard, et al.
Scientific Reports|June 9, 2021
A large mid-Holocene estuary was not present in the lower River Murray, AustraliaJ Tibby, B Bourman, C Wilson, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 DiabetesXuqing Zhang, Chaozhong Cai, Zhihua Sui, et al.
Mabs|November 16, 2021
An efficient system for bioconjugation based on a widely applicable engineered O-glycosylation tagThomas V Murray, Kasia Kozakowska-McDonnell, Adam Tibbles, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3 beta (GSK-3 beta) inhibitorsLan Shen, Catherine Prouty, Bruce R Conway, et al.
Journal of Medicinal Chemistry|July 8, 2005
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitorsGee-Hong Kuo, Alan Deangelis, Stuart Emanuel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 1, 1997
Thunderstorm-related asthma--the epidemic of 24/25 June 1994K M Venables, U Allitt, C G Collier, et al.
AJNR. American Journal of Neuroradiology|February 10, 2026
A Comparative Evaluation of 7T MRI for Epilepsy with Deep-Learning-Based Image Reconstruction and Dynamic Parallel TransmissionErik H Middlebrooks, Justyna O Ekert, Xiangzhi Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2003
The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathwayP V Murray, M E R O'Brien, R Sayer, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogsShyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Pageof 27

Showing results (231-240 of 265) with videos related to

Sort By:
Pageof 27
SLAS Discovery : Advancing Life Sciences R & D|January 20, 2025
Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display libraryStacey E Chin, Pablo Gallego, Anna Aagaard, et al.
Scientific Reports|June 9, 2021
A large mid-Holocene estuary was not present in the lower River Murray, AustraliaJ Tibby, B Bourman, C Wilson, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 DiabetesXuqing Zhang, Chaozhong Cai, Zhihua Sui, et al.
Mabs|November 16, 2021
An efficient system for bioconjugation based on a widely applicable engineered O-glycosylation tagThomas V Murray, Kasia Kozakowska-McDonnell, Adam Tibbles, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3 beta (GSK-3 beta) inhibitorsLan Shen, Catherine Prouty, Bruce R Conway, et al.
Journal of Medicinal Chemistry|July 8, 2005
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitorsGee-Hong Kuo, Alan Deangelis, Stuart Emanuel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 1, 1997
Thunderstorm-related asthma--the epidemic of 24/25 June 1994K M Venables, U Allitt, C G Collier, et al.
AJNR. American Journal of Neuroradiology|February 10, 2026
A Comparative Evaluation of 7T MRI for Epilepsy with Deep-Learning-Based Image Reconstruction and Dynamic Parallel TransmissionErik H Middlebrooks, Justyna O Ekert, Xiangzhi Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2003
The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathwayP V Murray, M E R O'Brien, R Sayer, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogsShyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Pageof 27